AstraZenaca

Emergent Biosolutions, Insider Trading, and the Gemba Shuffle

FOIAengine: Media Requests Were Warnings, Months Before Bad News Hit In the early days of...

February 4, 2026

In the Red? AstraZeneca Acquires FibroGen, Inc.’s China...

Pharma giant AstraZeneca announced plans to acquire FibroGen, Inc.’s China subsidiary for approximately $160...

March 20, 2025